ADIL
ADIAL PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$5.05
+36.12%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
—
Return on equity
-198.7%
Return on assets
—
Return on invested capital
0.00x
Asset turnover
-$11.1M
Cash from operations
$11
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026